Oncomine Comprehensive Myeloid Panel Test
Introduction to the Test
The Oncomine Comprehensive Myeloid Panel Test is a state-of-the-art diagnostic tool that plays a vital role in the detection and management of myeloid malignancies, particularly leukemia. This test utilizes advanced next-generation sequencing (NGS) technology to analyze a wide range of genetic mutations associated with these conditions. By identifying specific mutations, healthcare providers can tailor treatment plans to individual patients, improving outcomes and enhancing the quality of care.
What the Test Measures
This comprehensive panel tests for a multitude of genetic mutations and fusion genes that are critical in the diagnosis and treatment of myeloid malignancies. It assesses the following components:
- ABL1, ASXL1, BCOR, BAALC, BRAF, CALR, CEBPA, CBL, CSF3R, DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS, MPL, MYD88, MYC, NPM1, NRAS, NF1, PTPN11, PHF6, PRPF8, RB1, RUNX1, SETBP1, SF3B1, SRSF2, SH2B3, SMC1A, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2
- Fusion Genes: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6, FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A, MLLT3, MLLT10, MECOM, MET, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM15, RUNX1, TCF3, TFE3
Who Should Consider This Test?
This test is particularly recommended for individuals exhibiting symptoms such as:
- Unexplained fatigue
- Frequent infections
- Unusual bleeding or bruising
- Family history of leukemia or other hematological malignancies
Consultation with a hematologist or oncologist is advised for those at risk or presenting symptoms.
Benefits of Taking the Test
- Provides comprehensive insights into genetic mutations associated with leukemia.
- Facilitates personalized treatment strategies based on individual genetic profiles.
- Helps in monitoring disease progression and response to therapy.
- Enhances patient understanding of their condition and potential treatment options.
Understanding Your Results
Results from the Oncomine Comprehensive Myeloid Panel Test will typically be available within 15 days. Your healthcare provider will help interpret these results, discussing any mutations detected and their implications for treatment. It is essential to have a thorough understanding of your results to make informed decisions about your health.
Test Name and Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
Oncomine Comprehensive Myeloid Panel Test | 88,920 KSh | 98,800 KSh |
Book Your Test Today!
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. Additionally, we offer a convenient home sample collection service. Don’t wait—take control of your health today!
To book the Oncomine Comprehensive Myeloid Panel Test, call or WhatsApp us at +254713408028.